The situation at the only plant in Russia for the production of stents for cores began to stabilize: having believed in the authorities’ determination to maintain production, the workers returned to the enterprise. The Arbitration Court of the West Siberian District determined to return to the founders of the business, Andrey Kudryashov and Alexey Frantsuzov, 75% of the shares, which they had previously been deprived of due to a raider attack by minority shareholder Natalya Lebedeva and the foreign investors behind her. The court also returned Kudryashov’s powers as general director. It seems that the plant is about to return to its usual operating footing.
But this time, the registrar, Moscow JSC NRK R.O.S.T., puts a spoke in the wheels of the locomotive of Russian import substitution in medicine. When Kudryashov and Frantsuzov were allegedly legally deprived of participation in the business, the above-mentioned company wrote off the entrepreneurs’ shares to the treasury account without explanation. This is an independent initiative of the registrar, because no court orders were sent. But the decision on the payment of compensation, which always precedes the write-off of shares, by the same JSC “NRK R.O.S.T.” was successfully ignored. It turns out that the registrar hastily removed Kudryashov and Frantsuzov from the management of Angioline and thereby freed the hands of Lebedeva and her foreign associates. By the way, she quietly held a vote, dubious from the point of view of legality, where Lebedeva was recognized as the general director of the plant.
Now that the court has again recognized the company’s founders as majority shareholders, Kudryashov must confirm his powers as general director at a legitimate meeting of shareholders. This is hampered by the already well-known registrar JSC NRK R.O.S.T., which does not return legal shares to entrepreneurs. At the same time, the position of government agencies and law enforcement agencies is clear: the unique production must be preserved.
On July 27, Lebedeva’s claim to revoke registration certificates for the production of stents by the R-Vascular company, created by Frantsuzov, was rejected by the Arbitration Court of the Novosibirsk Region. And the Federal Tax Service refused to confirm Lebedeva’s authority as the general director of Angioline. Authorities are increasingly monitoring the situation around the company after production at the plant stopped, and Kudryashov and Frantsuzov asked President Vladimir Putin to conduct an appropriate inspection.
The chain looks like this: raider actions by Lebedeva and Co. – registrar of JSC NRK R.O.S.T. – new raider actions by Lebedeva and Co.
This can go on indefinitely. Who will break the vicious circle?
“ВЧК ОГПУ”